IRWD (STOCKS)
Ironwood Pharmaceuticals, Inc. - Class A
$3.730000
+0.100000 (+2.75%)
Prev close: $3.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas A. McCourt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $594.35M
- Employees
- 253
- P/E (TTM)
- 24.63
- P/B (TTM)
- -2.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $296.15M |
| Benefits Costs and Expenses | $226.13M |
| Costs And Expenses | $197.65M |
| Nonoperating Income/Loss | -$28.48M |
| Operating Expenses | $197.65M |
| Selling, General, and Administrative Expenses | $82.26M |
| Research and Development | $95.14M |
| Other Operating Expenses | $20.26M |
| Operating Income/Loss | $98.50M |
| Income/Loss From Continuing Operations After Tax | $24.02M |
| Income/Loss From Continuing Operations Before Tax | $70.03M |
| Income Tax Expense/Benefit | $46.01M |
| Income Tax Expense/Benefit, Current | $5.21M |
| Income Tax Expense/Benefit, Deferred | $40.80M |
| Net Income/Loss | $24.02M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $24.02M |
| Net Income/Loss Available To Common Stockholders, Basic | $24.02M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.15 |
| Diluted Earnings Per Share | $0.15 |
| Basic Average Shares | 161,842,000 |
| Diluted Average Shares | 162,983,000 |
| Assets | $396.90M |
| Current Assets | $274.18M |
| Noncurrent Assets | $122.72M |
| Fixed Assets | $3.41M |
| Other Non-current Assets | $119.32M |
| Liabilities | $658.74M |
| Current Liabilities | $242.22M |
| Accounts Payable | $2.90M |
| Wages | $11.59M |
| Other Current Liabilities | $227.73M |
| Noncurrent Liabilities | $416.52M |
| Equity | -$261.84M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$261.84M |
| Liabilities And Equity | $396.90M |
| Net Cash Flow From Operating Activities | $127.04M |
| Net Cash Flow From Operating Activities, Continuing | $127.04M |
| Net Cash Flow From Investing Activities | -$34.00K |
| Net Cash Flow From Investing Activities, Continuing | -$34.00K |
| Net Cash Flow From Financing Activities | $216.00K |
| Net Cash Flow From Financing Activities, Continuing | $216.00K |
| Net Cash Flow | $127.23M |
| Net Cash Flow, Continuing | $127.23M |
| Comprehensive Income/Loss | $22.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $22.03M |
| Other Comprehensive Income/Loss | -$1.98M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.98M |